Schering-Plough: A good company to work for
You may have a tough time finding a job at Amgen, but Science magazine's latest survey places the biotech company as the third best biopharma in the world to work for. Genentech, which ruled the number one spot for six years running, has had to bow out and let Germany's Boehringer Ingelheim take the lead position. But perhaps the biggest surprise of the year belonged to Schering-Plough, which jumped from 17th last year to fourth this year. Why the big change? Schering-Plough puts its poll vault down to its emphasis on acting like a small company. Participants, meanwhile, say that a new spirit of openness, ethics and honesty can help transform the drug industry's shoddy public reputation.
- here's the report for more
Related Articles:
Biochemists fetch highest salaries in life sciences. Report
Pfizer pursued Genentech employee for R&D spot. Report
Read more on: Amgen | Genentech | Boehringer Ingelheim | Schering-Plough
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


